EFFECTS OF FR50948, A NEW ORALLY ACTIVE ANTIALLERGIC AGENT, IN EXPERIMENTAL ALLERGIC MODELS

被引：5
|
作者：
HIROI, J
OHARA, K
KOBAYASHI, K
FUJITSU, T
FUJII, T
MOTOYAMA, Y
MORI, J
SHIBAYAMA, F
机构：
来源：
JAPANESE JOURNAL OF PHARMACOLOGY | 1988年 / 46卷 / 04期
关键词：
D O I：
10.1254/jjp.46.337
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：337 / 348
页数：12
相关论文
共 50 条
  • [41] T-8581, a new orally and parenterally active triazole antifungal agent: In vitro and in vivo evaluations
    Yotsuji, A
    Shimizu, K
    Araki, H
    Fujimaki, K
    Nishida, N
    Hori, R
    Annen, N
    Yamamoto, S
    Hayakawa, H
    Imaizumi, H
    Watanabe, Y
    Narita, H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) : 30 - 34
  • [42] Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors
    Maemoto, T
    Tada, M
    Mihara, T
    Ueyama, N
    Matsuoka, H
    Harada, K
    Yamaji, T
    Shirakawa, K
    Kuroda, S
    Akahane, A
    Iwashita, A
    Matsuoka, N
    Mutoh, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 96 (01) : 42 - 52
  • [43] DF 1601A, a new tartronate derivative orally active in osteopenia models in mice.
    Mosca, M
    Chiusaroli, R
    Bizzarri, C
    Allegretti, M
    Cesta, MC
    Gandolfi, CA
    Fiorentino, S
    Melillo, G
    Caselli, GF
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S180 - S180
  • [44] Antitumor activity of a new orally active organotin compound: a preliminary study in murine tumor models
    Barbieri, F
    Viale, M
    Sparatore, F
    Schettini, G
    Favre, A
    Bruzzo, C
    Novelli, F
    Alama, A
    ANTI-CANCER DRUGS, 2002, 13 (06) : 599 - 604
  • [45] PHARMACOLOGICAL STUDIES ON THE RESPIRATORY-TRACT (REPT-96) - EFFECTS OF NCO-650, A NEW ANTIALLERGIC AGENT, AND DISODIUM-CROMOGLYCATE ON ALLERGIC BRONCHIAL-ASTHMA IN RATS
    MISAWA, M
    TAKENOUCHI, K
    SHIRAKAWA, Y
    KAWAMURA, T
    YANAURA, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P246 - P246
  • [46] IMMUNOPHARMACOLOGICAL STUDIES ON TBX, A NEW ANTIALLERGIC DRUG .4. EFFECTS ON TYPE-II TO TYPE-IV ALLERGIC REACTIONS AND IMMUNOLOGICAL FUNCTIONS IN ANIMAL-MODELS
    YANAGIHARA, Y
    KASAI, H
    KAWASHIMA, T
    NINOMIYA, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1989, 51 (01): : 93 - 100
  • [47] Role of histamine in the inhibitory effects of phycocyanin in experimental models of allergic inflammatory response
    Remirez, D
    Ledón, N
    González, R
    MEDIATORS OF INFLAMMATION, 2002, 11 (02) : 81 - 85
  • [48] MECHANISM OF ANTIASTHMATIC ACTION OF A NEW ANTIALLERGIC AGENT, AA-673 .3. EFFECTS ON LIPOXYGENASE AND CYCLOOXYGENASE ACTIVITIES
    SAIJO, T
    MAKINO, H
    TAMURA, S
    KURIKI, H
    ASHIDA, Y
    MAKI, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 : P94 - P94
  • [49] ROLE OF PLATELET ACTIVATING FACTOR IN THE PATHOGENESIS OF ACTIVE AND PASSIVE MODELS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE RAT
    DESAI, S
    BARTON, R
    AGENTS AND ACTIONS, 1990, 31 (1-2): : 43 - 45
  • [50] Endometrial effects of three doses of trimegestone, a new orally active progestogen, on the postmenopausal endometrium
    Ross, D
    Godfree, V
    Cooper, A
    PryseDavies, J
    Whitehead, MI
    MATURITAS, 1997, 28 (01) : 83 - 88
12345